ARTEMIS DIANE T790M (An amino acid substitution at position 790 in EGFR, from a Threonine (T) to a Methionine (M)) mutation at hospital laboratories in comparison with central laboratory

Trial Identifier: D5160C00041
Sponsor: AstraZeneca
NCTID:: NCT02991274
Start Date: January 2017
Primary Completion Date: June 2018
Study Completion Date: June 2018
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Chinese Version

Trial Locations

Country Location
China Beijing, China
China Beijing, China, 100021
China Changchun, China, 130012
China Changchun, China, 130021
China Chengdu, China, 610041
China Guangzhou, China, 510080
China hangzhou, China, 310006
China Hangzhou, China, 310009
China Hangzhou, China, 310022
China Hangzhou, China, 310003
China Harbin, China, 150049
China Hefei, China, 230001
China Hohhot, China, 010017
China Ji Nan, China, 2501117
China Kunming, China, 650118
China Linhai, China, 317000
China Nanchang, China, 330006
China Nanjing, China, 210029
China Qingdao, China, 266071
China Shanghai, China, 200032
China Shanghai, China, 200433
China Shenyang, China, 110001
China Shenzhen, China, 518020
China Urumqi, China, 830054
China Ürümqi, China, 830000
China Wuhan, China, 430022
China Wuhan, China, 430030
China Xi'an, China, 710061
China Xi'An, China
China Yantai, China, 264000
China Zhengzhou, China, 450008